Palmerston North Hospital is the main public hospital in Palmerston North, New Zealand. The hospital is located at the northern end of Ruahine Street, 2 km northeast of The Square.

There are 354 beds in Palmerston North Hospital.

During the past decade, Palmerston North Hospital conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 5 clinical trials were completed, i.e. on average, 26.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 5 clinical trials were completed. i.e. 83.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Palmerston North Hospital" #1 sponsor was "Trans Tasman Radiation Oncology Group" with 6 trials, followed by "Hoffmann-La Roche" with 3 trials sponsored, "Merck Sharp & Dohme LLC" with 2 trials sponsored, "University of Auckland, New Zealand" with 2 trials sponsored and "University of Sydney" with 2 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Palmerston North Hospital" #1 collaborator was "National Health and Medical Research Council, Australia" with 4 trials as a collaborator, "Australian and New Zealand Urogenital and Prostate Cancer Trials Group" with 3 trials as a collaborator, "Cancer Trials Ireland" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator and "Australasian Leukaemia and Lymphoma Group" with 1 trials as a collaborator. Other collaborators include 27 different institutions and companies that were collaborators in the rest 37 trials.

According to Clinical.Site data, the most researched conditions in "Palmerston North Hospital" are "Prostate Cancer" (4 trials), "Leukemia" (2 trials), "Breast Cancer" (1 trials), "Carcinoma, Non-squamous Non-small-cell Lung" (1 trials) and "Carcinoma, Squamous Cell, Non-small-cell Lung" (1 trials). Many other conditions were trialed in "Palmerston North Hospital" in a lesser frequency.

Most popular intervention types in "Palmerston North Hospital" are "Drug" (30 trials), "Radiation" (9 trials), "Biological" (4 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (5 trials), "Cisplatin" (5 trials), "Placebo" (5 trials), "Rituximab" (4 trials) and "Cyclophosphamide" (3 trials). Other intervention names were less common.

The vast majority of trials in "Palmerston North Hospital" are 27 trials for "All" genders, 5 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Palmerston North Hospital". undefined are not yet recruiting, 5 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Palmerston North Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Palmerston North Hospital, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".